Inhaled insulin no longer marketed: discontinuation. Welcome news.
Pfizer has decided to stop selling Exubera. As this insulin form had a negative risk-benefit balance, this welcome decision will prevent patient exposure to a number of unnecessary risks.
D000280:Administration, Inhalation; D017277:Drug Approval; D005060:Europe; D006801:Humans; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000139:chemically induced; D014481:United States
D007328:Insulin